Article

TRANSCUP: a scalable workflow for predicting cancer of unknown primary based on next-generation transcriptome profiling

2019-09-23

Abstract excerpt

<h4>Summary</h4> Cancer of unknown primary site (CUP) accounts for 5% of all cancer diagnoses. These patients may benefit from more precise treatment when primary cancer site was identified. Advances in high-throughput sequencing have enabled cost-effective sequencing the transcriptome for clinical application. Here, we present a free, scalable and extendable software for CUP predication called TRANSCUP, which en...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 85942e99-6f44-520f-a3ee-9da7e34c4fb8
DOI: 10.1101/774315

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

TRANSCUP: a scalable workflow for predicting cancer of unknown primary based on next-generation transcriptome profilingDOI 10.1101/774315Read

CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligenceSemantic proximity Read

A computational framework to trace tumor tissue-of-origin of 19 cancer types based on RNA sequencingSemantic proximity Read

Application of Transcriptome–Based Gene Set Featurization for Machine Learning Model to Predict the Origin of Metastatic CancerSemantic proximity Read

Machine learning for pan-cancer classification based on RNA sequencing dataSemantic proximity Read

Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor typeSemantic proximity Read

Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patientsSemantic proximity Read

Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation featuresSemantic proximity Read

Validation of a transcriptome-based assay for classifying cancers of unknown primary originSemantic proximity Read

Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patientsSemantic proximity Read

Whole genome sequencing improves tissue of origin diagnosis and treatment options for cancer of unknown primarySemantic proximity Read

A cross-cohort computational framework to trace tumor tissue-of-origin based on RNA sequencingSemantic proximity Read

Real-world data analysis of patients with cancer of unknown primarySemantic proximity Read